Back to Search
KEVIN FLAHERTY, M.D.
M.D.
Ophthalmology Physician
NPI: 1740263581Individual
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
30290(WI)
Research & Publications (20)
Drug targeting of oncogenic pathways in melanoma.
PMID 19464605·Hematol Oncol Clin North Am·2009
6-review
Integrating BRAF/MEK inhibitors into combination therapy for melanoma.
PMID 19156138·Br J Cancer·2009
6-review
Preclinical and clinical development of targeted therapy in melanoma: attention to schedule.
PMID 19619259·Pigment Cell Melanoma Res·2009
8-other
Genetic subgrouping of melanoma reveals new opportunities for targeted therapy.
PMID 19351826·Cancer Res·2009
6-review
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers.
PMID 19549767·Clin Cancer Res·2009
8-other
Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008.
PMID 19659612·Pigment Cell Melanoma Res·2009
8-other
Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.
PMID 19179488·Am J Respir Crit Care Med·2009
8-other
Where are we with adjuvant therapy of stage III and IV melanoma in 2009?
PMID 19401062·J Natl Compr Canc Netw·2009
6-review
Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis.
PMID 19151189·Am J Respir Crit Care Med·2009
7-preclinical
Which questions remain unanswered following the successful development of sorafenib in hepatocellular carcinoma?
PMID 19092799·Nat Clin Pract Oncol·2009
8-other
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide.
PMID 19078992·J Invest Dermatol·2009
8-other
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis.
PMID 19074597·Am J Respir Crit Care Med·2009
8-other
Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.
PMID 19188183·Clin Cancer Res·2009
3-trial
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations.
PMID 18794803·Oncogene·2009
8-other
Development of a novel chemical class of BRAF inhibitors offers new hope for melanoma treatment.
PMID 19663727·Future Oncol·2009
7-preclinical
HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma.
PMID 19061835·Cancer Cell·2008
8-other
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas.
PMID 18790768·Mol Cancer Ther·2008
8-other
The future of tyrosine kinase inhibitors: single agent or combination?
PMID 18765158·Curr Oncol Rep·2008
6-review
Slow-onset asthma deaths have more eosinophils and health care utilization than rapid-onset deaths.
PMID 18692379·Respir Med·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 N 1ST ST
WAUSAU, WI 54403 - Phone
- (715) 261-8500
Quick Facts
- NPI
- 1740263581
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile